Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06487325
What this trial is testing

A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Fatty Liver Disease
Ma Zhe 120
Early research (Phase 1)Study completedNCT03674476
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Who this might be right for
NAFLDNonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04679376
What this trial is testing

Statins for the Treatment of NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Mayo Clinic 70
Testing effectiveness (Phase 2)UnknownNCT04702490
What this trial is testing

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more
Metacrine, Inc. 120
Not applicableActive Not RecruitingNCT06366425
What this trial is testing

Screening for Chronic Liver Diseases in General Population

Who this might be right for
Fibrosis, Liver
University Hospital, Montpellier 260
Not applicableStudy completedNCT04988204
What this trial is testing

Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Icahn School of Medicine at Mount Sinai 20
Not applicableUnknownNCT05733897
What this trial is testing

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
National Taiwan University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT03205150
What this trial is testing

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Who this might be right for
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 107
Testing effectiveness (Phase 2)Study completedNCT03639623
What this trial is testing

Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Transplant; ComplicationsNAFLD
Zydus Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT03445208
What this trial is testing

Experimental Medication BMS-986036 Given to Healthy Participants

Who this might be right for
Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease+1 more
Bristol-Myers Squibb 30
Not applicableStudy completedNCT04263376
What this trial is testing

Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD

Who this might be right for
ObesityDiabetes Mellitus, Type 2NAFLD
The Cleveland Clinic 18
Not applicableStudy completedNCT03988725
What this trial is testing

Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E

Who this might be right for
HIV Mono Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 27
Testing effectiveness (Phase 2)Ended earlyNCT01842282
What this trial is testing

Amlexanox for Type 2 Diabetes and Obesity

Who this might be right for
Diabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity
University of Michigan 7
Not applicableActive Not RecruitingNCT06735924
What this trial is testing

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Who this might be right for
MASLDMetabolic Dysfunction-Associated Steatotic Liver Disease
University of Alabama at Birmingham 28
Early research (Phase 1)Study completedNCT05733455
What this trial is testing

Effect of Alpelisib in Healthy Volunteers

Who this might be right for
Insulin ResistanceHyperinsulinemiaDyslipidemias
Columbia University 23
Testing effectiveness (Phase 2)Study completedNCT04801849
What this trial is testing

Vitamin E Dosing Study

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 200
Not applicableActive Not RecruitingNCT04132440
What this trial is testing

Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseasePhysician
M.D. Anderson Cancer Center 17
Not applicableStudy completedNCT02482558
What this trial is testing

Investigating the Effects of a High GI Versus a Low GI Diet on Hepatic Metabolism and Satiety Levels in Healthy Subjects

Who this might be right for
Healthy
Unilever R&D 8
Not applicableActive Not RecruitingNCT04227782
What this trial is testing

MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Oxford 40
Not applicableStudy completedNCT07021443
What this trial is testing

The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Universitair Ziekenhuis Brussel 50
Next Page